company background image
PGHL logo

Procter & Gamble Health NSEI:PGHL Stock Report

Last Price

₹5.24k

Market Cap

₹86.9b

7D

-3.1%

1Y

5.8%

Updated

31 Dec, 2024

Data

Company Financials +

Procter & Gamble Health Limited

NSEI:PGHL Stock Report

Market Cap: ₹86.9b

PGHL Stock Overview

Engages in the manufacture and marketing of pharmaceuticals and chemical products in India and internationally. More details

PGHL fundamental analysis
Snowflake Score
Valuation1/6
Future Growth1/6
Past Performance4/6
Financial Health5/6
Dividends3/6

My Notes

Capture your thoughts, links and company narrative

Procter & Gamble Health Limited Competitors

Price History & Performance

Summary of share price highs, lows and changes for Procter & Gamble Health
Historical stock prices
Current Share Price₹5,238.05
52 Week High₹5,850.00
52 Week Low₹4,636.55
Beta0.52
1 Month Change1.18%
3 Month Change-5.40%
1 Year Change5.76%
3 Year Change0.37%
5 Year Change22.42%
Change since IPO1,243.26%

Recent News & Updates

Here's Why Procter & Gamble Health Limited's (NSE:PGHL) CEO Compensation Is The Least Of Shareholders' Concerns

Nov 29
Here's Why Procter & Gamble Health Limited's (NSE:PGHL) CEO Compensation Is The Least Of Shareholders' Concerns

Procter & Gamble Health (NSE:PGHL) Is Due To Pay A Dividend Of ₹60.00

Nov 15
Procter & Gamble Health (NSE:PGHL) Is Due To Pay A Dividend Of ₹60.00

Risks To Shareholder Returns Are Elevated At These Prices For Procter & Gamble Health Limited (NSE:PGHL)

Nov 05
Risks To Shareholder Returns Are Elevated At These Prices For Procter & Gamble Health Limited (NSE:PGHL)

Recent updates

Here's Why Procter & Gamble Health Limited's (NSE:PGHL) CEO Compensation Is The Least Of Shareholders' Concerns

Nov 29
Here's Why Procter & Gamble Health Limited's (NSE:PGHL) CEO Compensation Is The Least Of Shareholders' Concerns

Procter & Gamble Health (NSE:PGHL) Is Due To Pay A Dividend Of ₹60.00

Nov 15
Procter & Gamble Health (NSE:PGHL) Is Due To Pay A Dividend Of ₹60.00

Risks To Shareholder Returns Are Elevated At These Prices For Procter & Gamble Health Limited (NSE:PGHL)

Nov 05
Risks To Shareholder Returns Are Elevated At These Prices For Procter & Gamble Health Limited (NSE:PGHL)

Procter & Gamble Health (NSE:PGHL) Has Announced A Dividend Of ₹60.00

Sep 28
Procter & Gamble Health (NSE:PGHL) Has Announced A Dividend Of ₹60.00

Procter & Gamble Health (NSE:PGHL) Has Announced A Dividend Of ₹60.00

Aug 27
Procter & Gamble Health (NSE:PGHL) Has Announced A Dividend Of ₹60.00

Earnings Not Telling The Story For Procter & Gamble Health Limited (NSE:PGHL)

Jun 08
Earnings Not Telling The Story For Procter & Gamble Health Limited (NSE:PGHL)

Weak Statutory Earnings May Not Tell The Whole Story For Procter & Gamble Health (NSE:PGHL)

Feb 14
Weak Statutory Earnings May Not Tell The Whole Story For Procter & Gamble Health (NSE:PGHL)

Procter & Gamble Health (NSE:PGHL) Has Announced That It Will Be Increasing Its Dividend To ₹50.00

Sep 29
Procter & Gamble Health (NSE:PGHL) Has Announced That It Will Be Increasing Its Dividend To ₹50.00

Procter & Gamble Health's (NSE:PGHL) Shareholders Will Receive A Bigger Dividend Than Last Year

Sep 10
Procter & Gamble Health's (NSE:PGHL) Shareholders Will Receive A Bigger Dividend Than Last Year

Procter & Gamble Health's (NSE:PGHL) Shareholders Will Receive A Bigger Dividend Than Last Year

Aug 27
Procter & Gamble Health's (NSE:PGHL) Shareholders Will Receive A Bigger Dividend Than Last Year

A Look At The Fair Value Of Procter & Gamble Health Limited (NSE:PGHL)

Mar 30
A Look At The Fair Value Of Procter & Gamble Health Limited (NSE:PGHL)

We Think The Compensation For Procter & Gamble Health Limited's (NSE:PGHL) CEO Looks About Right

Nov 17
We Think The Compensation For Procter & Gamble Health Limited's (NSE:PGHL) CEO Looks About Right

Procter & Gamble Health (NSE:PGHL) Has Announced That Its Dividend Will Be Reduced To ₹11.50

Oct 23
Procter & Gamble Health (NSE:PGHL) Has Announced That Its Dividend Will Be Reduced To ₹11.50

Procter & Gamble Health's (NSE:PGHL) Dividend Will Be Reduced To ₹11.50

Oct 09
Procter & Gamble Health's (NSE:PGHL) Dividend Will Be Reduced To ₹11.50

Procter & Gamble Health's (NSE:PGHL) Problems Go Beyond Weak Profit

Feb 16
Procter & Gamble Health's (NSE:PGHL) Problems Go Beyond Weak Profit

Do Procter & Gamble Health's (NSE:PGHL) Earnings Warrant Your Attention?

Oct 04
Do Procter & Gamble Health's (NSE:PGHL) Earnings Warrant Your Attention?

Here's Why I Think Procter & Gamble Health (NSE:PGHL) Is An Interesting Stock

May 10
Here's Why I Think Procter & Gamble Health (NSE:PGHL) Is An Interesting Stock

Would Procter & Gamble Health Limited (NSE:PGHL) Be Valuable To Income Investors?

Mar 23
Would Procter & Gamble Health Limited (NSE:PGHL) Be Valuable To Income Investors?

Is Weakness In Procter & Gamble Health Limited (NSE:PGHL) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?

Mar 02
Is Weakness In Procter & Gamble Health Limited (NSE:PGHL) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?

Should You Be Adding Procter & Gamble Health (NSE:PGHL) To Your Watchlist Today?

Jan 31
Should You Be Adding Procter & Gamble Health (NSE:PGHL) To Your Watchlist Today?

Here's What Procter & Gamble Health Limited's (NSE:PGHL) Shareholder Ownership Structure Looks Like

Jan 10
Here's What Procter & Gamble Health Limited's (NSE:PGHL) Shareholder Ownership Structure Looks Like

Is Procter & Gamble Health Limited (NSE:PGHL) An Attractive Dividend Stock?

Dec 19
Is Procter & Gamble Health Limited (NSE:PGHL) An Attractive Dividend Stock?

Is Procter & Gamble Health Limited's (NSE:PGHL) Latest Stock Performance A Reflection Of Its Financial Health?

Dec 01
Is Procter & Gamble Health Limited's (NSE:PGHL) Latest Stock Performance A Reflection Of Its Financial Health?

Shareholder Returns

PGHLIN PharmaceuticalsIN Market
7D-3.1%2.0%-0.3%
1Y5.8%39.5%16.3%

Return vs Industry: PGHL underperformed the Indian Pharmaceuticals industry which returned 39.5% over the past year.

Return vs Market: PGHL underperformed the Indian Market which returned 16.3% over the past year.

Price Volatility

Is PGHL's price volatile compared to industry and market?
PGHL volatility
PGHL Average Weekly Movement4.1%
Pharmaceuticals Industry Average Movement6.0%
Market Average Movement6.2%
10% most volatile stocks in IN Market9.1%
10% least volatile stocks in IN Market4.1%

Stable Share Price: PGHL has not had significant price volatility in the past 3 months compared to the Indian market.

Volatility Over Time: PGHL's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19671,336Milind Thattewww.pghealthindia.com

Procter & Gamble Health Limited engages in the manufacture and marketing of pharmaceuticals and chemical products in India and internationally. The company provides over-the-counter products, vitamins, minerals, and supplements. It offers its products under the Polybion, Cosome, Evion, Neurobion, Nasivion, Livogen, and Seven Seas brands.

Procter & Gamble Health Limited Fundamentals Summary

How do Procter & Gamble Health's earnings and revenue compare to its market cap?
PGHL fundamental statistics
Market cap₹86.94b
Earnings (TTM)₹2.18b
Revenue (TTM)₹11.60b

39.9x

P/E Ratio

7.5x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
PGHL income statement (TTM)
Revenue₹11.60b
Cost of Revenue₹3.31b
Gross Profit₹8.28b
Other Expenses₹6.11b
Earnings₹2.18b

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

Feb 12, 2025

Earnings per share (EPS)131.17
Gross Margin71.42%
Net Profit Margin18.77%
Debt/Equity Ratio1.8%

How did PGHL perform over the long term?

See historical performance and comparison

Dividends

2.3%

Current Dividend Yield

91%

Payout Ratio

Does PGHL pay a reliable dividends?

See PGHL dividend history and benchmarks
When do you need to buy PGHL by to receive an upcoming dividend?
Procter & Gamble Health dividend dates
Ex Dividend DateNov 28 2024
Dividend Pay DateJan 04 2025
Days until Ex dividend34 days
Days until Dividend pay date3 days

Does PGHL pay a reliable dividends?

See PGHL dividend history and benchmarks

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/31 19:57
End of Day Share Price 2024/12/31 00:00
Earnings2024/09/30
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Procter & Gamble Health Limited is covered by 5 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Rohit BhatBatlivala & Karani Securities India Pvt. Ltd.
Ranjit KapadiaCentrum Broking Limited
Anil BurraFirstCall Research